BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26164736)

  • 1. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
    Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
    Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The philosophy of treatment of uveitis: past, present and future.
    Kruh J; Foster CS
    Dev Ophthalmol; 2012; 51():1-6. PubMed ID: 22517200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory Therapy in Uveitis.
    Tomkins-Netzer O; Talat L; Ismetova F; Samy A; Lightman S
    Dev Ophthalmol; 2016; 55():265-75. PubMed ID: 26501368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Road to remission: a comprehensive review of therapy in uveitis.
    Siddique SS; Shah R; Suelves AM; Foster CS
    Expert Opin Investig Drugs; 2011 Nov; 20(11):1497-515. PubMed ID: 21936708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of uveitis.
    Lee FF; Foster CS
    Expert Opin Pharmacother; 2010 May; 11(7):1135-46. PubMed ID: 20367272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive Treatment of Non-infectious Uveitis: History and Current Choices.
    Zhao C; Zhang M
    Chin Med Sci J; 2017 Apr; 32(1):48-61. PubMed ID: 28399985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ocular inflammation in children.
    Thadani SM; Foster CS
    Paediatr Drugs; 2004; 6(5):289-301. PubMed ID: 15449968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapies in Development for Non-Infectious Uveitis.
    Sadiq MA; Agarwal A; Hassan M; Afridi R; Sarwar S; Soliman MK; Do DV; Nguyen QD
    Curr Mol Med; 2015; 15(6):565-77. PubMed ID: 26238367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Biol Ther; 2014 Nov; 14(11):1651-66. PubMed ID: 25226284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biologic agents in the management of uveitis.
    Trivedi A; Katelaris C
    Intern Med J; 2019 Nov; 49(11):1352-1363. PubMed ID: 30582273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopharmacotherapy of non-infectious uveitis: where do we stand?
    Agrawal R; Lee C; Phatak S; Pavesio C
    Expert Opin Biol Ther; 2014 Dec; 14(12):1719-22. PubMed ID: 25244075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical approach to the use of corticosteroids in patients with uveitis.
    Cunningham ET; Wender JD
    Can J Ophthalmol; 2010 Aug; 45(4):352-8. PubMed ID: 20648092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in corticosteroid therapy for uveitis.
    Taylor SR; Isa H; Joshi L; Lightman S
    Ophthalmologica; 2010; 224 Suppl 1():46-53. PubMed ID: 20714181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of durable remission in ocular inflammatory diseases.
    Cervantes-Castaneda RA; Bhat P; Fortuna E; Acevedo S; Foster CS
    Eur J Ophthalmol; 2009; 19(1):118-23. PubMed ID: 19123158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.
    Okada AA
    Ocul Immunol Inflamm; 2005; 13(5):335-51. PubMed ID: 16419419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Immunosuppressive Therapies in Uveitis Treatment.
    Mérida S; Palacios E; Navea A; Bosch-Morell F
    Int J Mol Sci; 2015 Aug; 16(8):18778-95. PubMed ID: 26270662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.